Pediatric Health Research Consultant, White Salmon, WA 98672, USA.
J Public Health Dent. 2013 Winter;73(1):24-31. doi: 10.1111/j.1752-7325.2012.00348.x. Epub 2012 Jun 26.
To test the efficacy of 10% chlorhexidine (CHX) dental varnish applied to the mothers' dentition in preventing caries in American Indian children.
This was a placebo-controlled, double-blind, randomized clinical trial. Mother-child pairs were enrolled when the child was 4.5-6.0 months. Mothers received 4 weekly applications of the study treatment (CHX or placebo) followed by single applications when her child was age 12 and 18 months. Children received caries examinations at enrollment, 12, 18 and 24 months. Analyses were limited to the intent-to-treat (ITT) group: children whose mothers received the first study treatment and who received at least one post-baseline exam. The outcome variable was the number of new carious surfaces (NNCS) at the child's last visit. Wilcoxon nonparametric and Fisher's exact tests were used to test differences between the active and placebo groups.
We randomized 414 mother-child pairs, with 367 (88.6%) included in the ITT group (active = 188, placebo = 179). The proportion of children caries-free at their final exam was 51.1% and 50.8% for the active and placebo groups (P > 0.99). The mean NNCS for the active and placebo groups was 3.82 (standard deviation [SD] = 8.18) and 3.80 (SD = 6.08), respectively (P = 0.54). The proportion with NNCS > 6 was 18.1% for active children versus 27.9% for placebo (relative risk [RR] = 0.65, P = 0.03). The number needed to treat to shift one child from NNCS > 6 to a lower severity was 10.2.
In this population CHX varnish did not reduce the mean NNCS or proportion of children with caries, but did reduce the proportion with severe caries.
检验在母亲牙齿上使用 10%的洗必泰(CHX)牙漆预防美洲印第安儿童龋齿的效果。
这是一项安慰剂对照、双盲、随机临床试验。当孩子 4.5-6.0 个月大时,母亲和孩子被纳入研究。母亲接受了 4 次每周的研究治疗(CHX 或安慰剂),然后在孩子 12 个月和 18 个月时再进行单次应用。孩子在入组时、12 个月、18 个月和 24 个月时接受龋齿检查。分析仅限于意向治疗(ITT)组:母亲接受了第一次研究治疗且至少接受了一次基线后检查的孩子。因变量是孩子最后一次就诊时的新龋面数(NNCS)。Wilcoxon 非参数和 Fisher 精确检验用于检验活性组和安慰剂组之间的差异。
我们随机分配了 414 对母婴,其中 367 对(88.6%)被纳入 ITT 组(活性组=188,安慰剂组=179)。最后一次检查时无龋齿的孩子比例为活性组 51.1%,安慰剂组 50.8%(P>0.99)。活性组和安慰剂组的 NNCS 平均值分别为 3.82(标准差[SD]=8.18)和 3.80(SD=6.08)(P=0.54)。NNCS>6 的比例,活性组为 18.1%,安慰剂组为 27.9%(相对风险[RR]=0.65,P=0.03)。需要治疗的人数从 NNCS>6 转移到较低严重程度的人数为 10.2。
在该人群中,CHX 牙漆并未降低 NNCS 的平均值或患龋齿儿童的比例,但确实降低了严重龋齿的比例。